Localized IDO Delivery via Granular PEG Hydrogel Enhances Therapeutic Control of Psoriasis
Journal of Biomedical Materials Research Part A · 2026-11 · 114 (11)
DOI: 10.1002/jbm.a.70182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, online erschienen am 01.11.2026. Verfasst von Adrienne E Widener und 7 weiteren Autor:innen. Beteiligte Einrichtung: J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Polyethylene Glycols, Indoleamine-Pyrrole 2,3,-Dioxygenase, Psoriasis, Hydrogels. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Breakthrough T1D, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Enzyme therapeutics are often limited by poor stability, rapid clearance, and systemic effects that reduce therapeutic efficacy and necessitate high dosing. Enzyme‐biomaterial conjugation can address these limitations and improve outcomes by localizing therapeutics at the tissue site of intended action. In particular, indoleamine 2,3‐dioxygenase (IDO), a potent immunomodulatory enzyme, has demonstrated therapeutic effectiveness when retained locally at sites of inflammation through fusion to a carbohydrate‐binding protein. Here, we report a complementary biomaterial‐mediated delivery strategy to prolong retention time and investigate efficacy in an imiquimod‐induced model of psoriasis. IDO maintained enzyme activity after bioconjugation to polyethylene glycol maleimide (PEG‐MAL) microgels. Localized delivery of IDO‐conjugated microgels reduced psoriatic scores compared to soluble IDO or unconjugated microgels. Additionally, fibrotic capsule thickness decreased 30% in the IDO‐conjugated microgel group compared to the unconjugated microgel. These findings demonstrate the efficacy of localized IDO delivery via covalent attachment to granular hydrogels, which may serve as a platform for other immunomodulatory enzymes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, Florida, USA.
- Department of Pharmacology and Therapeutics, University of Florida, Gainesville, Florida, USA.
- University of Florida Diabetes Institute, Gainesville, Florida, USA.
- Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida, USA.
ORCID-Profile: Adrienne E Widener, Jennifer A Simonovich, Cameron T Manson, Madeline J Fuchs, Isabella Pinto, Gregory A Hudalla, Benjamin G Keselowsky, Edward A Phelps
Förderung
- Breakthrough T1D
- NIH HHS
- National Institutes of Health
Zitieren
APA
Widener, A. E., Simonovich, J. A., Manson, C. T., Fuchs, M. J., Pinto, I., Hudalla, G. A., Keselowsky, B. G., & Phelps, E. A. (2026). Localized IDO Delivery via Granular PEG Hydrogel Enhances Therapeutic Control of Psoriasis. Journal of Biomedical Materials Research Part A, 114(11). https://doi.org/10.1002/jbm.a.70182
Vancouver
Widener AE, Simonovich JA, Manson CT, Fuchs MJ, Pinto I, Hudalla GA, et al. Localized IDO Delivery via Granular PEG Hydrogel Enhances Therapeutic Control of Psoriasis. Journal of Biomedical Materials Research Part A. 2026;114(11). doi:10.1002/jbm.a.70182
BibTeX
@article{Widener2026,
author = {Widener, Adrienne E and Simonovich, Jennifer A and Manson, Cameron T and Fuchs, Madeline J and Pinto, Isabella and Hudalla, Gregory A and Keselowsky, Benjamin G and Phelps, Edward A},
title = {Localized IDO Delivery via Granular PEG Hydrogel Enhances Therapeutic Control of Psoriasis},
journal = {Journal of Biomedical Materials Research Part A},
year = {2026},
volume = {114},
number = {11},
doi = {10.1002/jbm.a.70182}
}
EUVIMED